Elmar Kraus analyst DZ BANK

Currently out of the existing stock ratings of Elmar Kraus, 7 are a BUY (53.85%), 6 are a HOLD (46.15%).

Elmar Kraus

Work Performance Price Targets & Ratings Chart

Analyst Elmar Kraus works at DZ BANK with a stock forecast success ratio of 68.33% fulfilled within 283.6 days on average.

Elmar Kraus’s has documented 26 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LLY, Eli Lilly and Company at 21-Feb-2024.

Wall Street Analyst Elmar Kraus

Analyst best performing recommendations are on BIIB (BIOGEN).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 1/21/2022. The price target of $291 was fulfilled within 75 days with a profit of $53.95 (22.76%) receiving and performance score of 3.03.

Average potential price target upside

BIIB Biogen LLY Eli Lilly and Company AZN AstraZeneca PLC ADR GILD Gilead Sciences AMGN Amgen

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

270

$52.49 (24.13%)

270

6 days ago

24/37 (64.86%)

$61.1 (29.25%)

326

Hold

200

$-17.51 (-8.05%)

215

10 days ago

20/23 (86.96%)

$-2.46 (-1.22%)

221

Buy

294

$76.49 (35.17%)

305

11 days ago

7/22 (31.82%)

$92.01 (45.55%)

255

Hold

214

$-3.51 (-1.61%)

250

18 days ago

4/15 (26.67%)

$21.84 (11.37%)

68

Hold

213

$-4.51 (-2.07%)

239

18 days ago

22/24 (91.67%)

$20.84 (10.85%)

139

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Elmar Kraus is most bullish on?

Potential upside of $85.03 has been obtained for LLY (ELI LILLY AND COMPANY)

Which stock is Elmar Kraus is most reserved on?

Potential downside of $24.49 has been obtained for BIIB (BIOGEN)

What Year was the first public recommendation made by Elmar Kraus?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?